Houston, TX, Feb. 28, 2018 --
Ultra Petroleum Corp. (NASDAQ: UPL) announces the following Webcast to discuss its fourth quarter 2017 financial and operating results:
What: Ultra Petroleum Corp. Fourth Quarter 2017 Results Webcast
When: February 28, 2018 at 11:00 a.m. Eastern Standard Time
Where: http://www.ultrapetroleum.com
How: Live over the internet via the website address above
Contact: Sandi Kraemer, [email protected], 281-582-6613
If you are unable to participate during the live Webcast, the conference call will be archived and can be accessed from Ultra’s home page at http://www.ultrapetroleum.com.
About Ultra Petroleum
Ultra Petroleum Corp. is an independent energy company engaged in domestic natural gas and oil exploration, development and production. The company is listed on NASDAQ and trades under the ticker symbol “UPL”. Additional information on the company is available at www.ultrapetroleum.com.
This release can be found at www.ultrapetroleum.com.
For further information contact:
Sandi Kraemer
Email: [email protected]
Phone: 281-582-6613


Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
OpenAI Restricts Astra AI Over Cyberattack Risks
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



